Redesign Science is a biotech startup founded in 2017 with a slogan "Biology Simulated". The company operates at the intersection of physics-based molecular simulation and deep learning to develop generative AI for drug discovery. Their focus is on creating first-in-class Protein Interaction Modulators targeting validated targets associated with the progression of multiple oncogenic and inflammatory diseases.
The startup operates in the industries of Biotechnology, Health Care, and Pharmaceutical and is headquartered in the United States.
Redesign Science has not disclosed its last investment or the participating investors.
There is no investment information
No recent news or press coverage available for Redesign Science.